Skip to main content
VVT MED INC. logo

VVT MED INC. — Investor Relations & Filings

Ticker · VVTM ISIN · CA91841T1084 TSXV Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2025-07-24 Regulatory Filings
Country CA Canada
Listing TSXV VVTM

About VVT MED INC.

https://www.vvtmed.com/

VVT MED INC. develops, manufactures, and commercializes minimally invasive, non-thermal, non-tumescent (NT-NT) solutions for the treatment of varicose veins and chronic venous disorders. The company's technology centers on the ScleroSafe Platform, a patented delivery system for Endovenous Chemical Ablation (ECA). ScleroSafe is designed to simplify procedures, shorten treatment times, and minimize patient recovery compared to traditional surgical and ablation methods. Products like ScleroSafe and V-Block, which treats severely dilated Great Saphenous Vein conditions, offer enhanced safety and efficacy. The platform holds regulatory clearances including FDA 510(k) and CE approval.

Recent filings

Filing Released Lang Actions
Certificate and articles of change of name.pdf
Regulatory Filings
2025-07-24 English
News release - English.pdf
Regulatory Filings
2025-07-23 English
News release - English.pdf
Share Issue/Capital Change Classification · 87% confidence The document is a corporate press release announcing a share consolidation (4:67 ratio reverse split), a name change in advance of a proposed reverse takeover, and related details on concurrent private placement financings. It is an announcement of a capital structure change (reverse stock split) rather than a full report, earnings release, or regulatory filing on performance. This fits the “Share Issue/Capital Change” category (SHA).
2025-07-16 English
News release - English.pdf
M&A Activity Classification · 93% confidence The document is a corporate press release providing a detailed update on a proposed reverse takeover transaction (an M&A event) including financing conditions, TSXV approvals, and transaction closing timing. This falls squarely under the definition of M&A Activity (Code: TAR).
2025-07-01 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 84% confidence The document is a standalone certification form (Form 52-109FV2) under Canadian NI 52-109 for interim filings, signed by the CFO. It is not the interim financial report itself but a regulatory certificate accompanying it. It does not contain financial statements or MD&A content, nor does it announce the release of a new report. It therefore falls under the general ‘Regulatory Filings’ category rather than an Interim Report or Earnings Release.
2025-05-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 75% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate,” a CEO certification under Canadian NI 52-109 certifying the interim financial report and MD&A for the period ending March 31, 2025. It is not the interim report itself, nor an announcement of a report, but a required regulatory certification. It does not fit any other specific category, so it falls under the general Regulatory Filings (RNS) fallback.
2025-05-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.